MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with D

Disopyramide

Disopyramide 25mg capsules

No stability information

Stability notes for Disopyramide 25mg capsules

There are no stability notes for this medicine.

Supplier

Disopyramide 25mg capsules (Special Order)

Disopyramide 100mg capsules

Use with caution

Stability notes for Disopyramide 100mg capsules

Protect from light. Store in an airtight container.

Provenance

This compatibility recommendation is derived from Rythmodan 100mg capsules (Neon Healthcare Ltd).

Suppliers (4) of Disopyramide 100mg capsules
Disopyramide 100mg capsules (Drugsrus Ltd)
Disopyramide 100mg capsules (Imported)
Disopyramide 100mg capsules (Sigma Pharmaceuticals Plc)
Rythmodan 100mg capsules (Neon Healthcare Ltd)

Disopyramide 250mg modified-release tablets

No stability information

Stability notes for Disopyramide 250mg modified-release tablets

There are no stability notes for this medicine.

Suppliers (4) of Disopyramide 250mg modified-release tablets
Disopyramide 250mg modified-release tablets (Imported)
Disopyramide 250mg modified-release tablets (Neon Healthcare Ltd)
Rythmodan Retard 250mg tablets (Drugsrus Ltd)
Rythmodan Retard 250mg tablets (Neon Healthcare Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.